期刊文献+

慢性心力衰竭患者血清hs-cTnT及galectin-3水平及其临床意义 被引量:10

Clinical Significance of Galectin-3 and Hypersensitive Cardiac Troponin T Levels in Patients with Chronic Heart Failure
原文传递
导出
摘要 目的:探讨慢性心力衰竭(chronic heart failure,CHF)患者半乳糖凝集素-3(Galactose lectin-3,galectin-3)和高敏肌钙蛋白-T(high-sensitivity cardiac troponin T,hs-cTnT)的水平,并评估其对CHF患者近期预后的预测价值。方法:选取CHF住院患者共220例,按美国纽约心脏病协会(NY-HA)心功能分级分为Ⅱ-Ⅳ级,检测患者血清galectin-3、hs-cTnT、氨基末端B型脑钠肽前体(NT-proBNP)水平和动态心电图及超声心动图变化。出院90d后随访,记录主要心脏不良事件(MACE)的发生情况。结果:CHF患者血清galectin-3、hs-cT-nT水平均随心功能分级增高而升高(P〈0.05);相关性分析显示galectin-3与hs-c Tn T正相关(r=0.822,P〈0.05);发生MACE组血清galectin-3、hs-c Tn T水平高于未发生MACE组[(19.9±4.42)ng/mL vs(17.4±3.46)ng/mL及(0.030±0.015)ng/mL vs(0.022±0.011)ng/mL,P均〈0.05];galectin-3≥22.885ng/mL组恶性心律失常及MACE发生率更高(分别为78.6%vs9.9%及85.71%vs 18.68%,P均〈0.05),hs-cTnT阳性组恶性心律失常及MACE发生率亦更高(分别为24.7%vs 3.6%及33.8%vs10.7%,P均〈0.05)。结论:血清galectin-3、hs-cTnT与CHF的严重程度相关,对评估CHF患者的近期预后有重要参考价值。 Objective: To evaluate the levels of galectin-3 and hypersensitive cardiac troponin T (hs-cTnT) and examine their prognostic values in patients with chronic heart failure (CHF). Methods: A total of 110 CHF patients with New York Heart Association (NYHA) II -1V were recruited. The serum levels of gatectin-3, hs-cTnT and N-terminal pro-brain natfiuretic peptide (NT-proBNP), dynamic electrocardiogram and echocardiography were detected. Follow-ups were conduced within 90 days of discharge to monitor major adverse cardiac events (MACE), readmissions or mortality. Results: The serum levels of galectin-3 and hs-cTnT rose with higher heart func-tion classification(P〈0.05). Correlation analysis showed that galectin-3 was positively correlated with hs-cTnT (r =0.823 ,P〈0. 05). Compared with the non-MACE group, the MACE group had higher levels ofgalectin-3 (19.9± 4.42 vs 17.4± 3.46 ng/mL, P〈0.05) and hs-cTnT (0.030± 0.015 vs 0.022± 0.011 ng/mL). And the galectin-3 elevation group had higher incidence rates of malignant arrhythmia (78.6% vs 9.9%,P〈0.05)and MACE (85.71% vs 18.68%, P〈0.05). The hs-cTnT positive group also had higher incidence rates of malignant arrhythmia (24.7% vs 3.6%, P〈0.05) and MACE(33.8% vs 10.7%, P〈0.05). Conclusion: The serum levels of galectin-3 and hs-cTnT were positively correlated with the severity of CHF and had important values for predicting the short-term prognosis of CHF.
出处 《现代生物医学进展》 CAS 2016年第24期4723-4726,共4页 Progress in Modern Biomedicine
基金 云南省教育厅科学研究基金项目(2012Z076)
关键词 半乳糖凝集素3 高敏肌钙蛋白-T 慢性心力衰竭 预后 Galectin-3 High-sensitivity cardiac troponin T(hs-cTnT) Chronic Heart Failure(CHF) Prognosis
  • 相关文献

参考文献20

  • 1Gruson D, Ko G. Galectins testing: new promises for the diagnosis and risk stratification of chronic diseases? [J]. Clin Biochem, 2012, 45 (10-11): 719-726.
  • 2de Boer RA, Daniels LB, Maisel AS, et al. State of the Art: Newer biomarkers in heart failure[J]. Eur l Heart Fail, 2015, 17(6): 559-569.
  • 3陆再英,钟南山.内科学[M].北京:人民卫生出版社,2012:336-337.
  • 4Jiang BH, Nguyen QT, Tardif JC, et al. Single measurement of troponin T for early prediction of infarct size, congestive heart failure, and pulmonary hypertension in an animal model of myocardial infarction[J]. Cardiovase Pathol, 2011, 20(3): e85-89.
  • 5NO ~ez J, Rabinovich GA, Sandino J, et al. Prognostic value of the interaction between galectin-3 and antigen carbohydrate 125 in acute heart failure[J]. PLoS One, 2015, 10(4): e0122360.
  • 6程丽芳,韩燕如.充血性心衰患者血清肌钙蛋白、心肌酶谱的变化研究[J].海南医学院学报,2014,20(1):41-43. 被引量:18
  • 7de Boer RA, Yu L, van Veldhuisen DJ. Galectin-3 in cardiac remodeling and heart failure[J]. Curt Heart Fail Rep, 2010, 7(1): 1-8.
  • 8Gruson D, Ferracin B, Aim SA, et al. Comparison of fibroblast growth factor 23, soluble ST2 and Galectin-3 for prognostication of cardiovascular death in heart failure patients [J]. Int J Cardiol,2015, 189:185-187.
  • 9Felker GM, Fiuzat M, Shaw LK, et al. Galecfin-3 in ambulatory patients with heart failure: results from the I-IF-ACTION study [J]. Circ Heart Fail, 2012, 5(1): 72-78.
  • 10张慧娟,牛楠,曲鹏,王虹艳,丁彦春,陈亮.慢性心力衰竭患者血清半乳凝集素3水平的变化[J].中华高血压杂志,2012,20(9):833-837. 被引量:9

二级参考文献27

  • 1陈灏珠.实用内科学[M].北京:人民卫生出版社,2005.1850.
  • 2MeCullough PA, Olobatoke A, Vanhecke TE. Galectin 3: a no- vel blood lest for the evaluation and management of patients with heart failure[J]. Rev Cardiovasc Med,2011,12(4) :200-210.
  • 3Opie I,H, Commerford PJ, Gersh F,J, et al. Controversies in ven- t ricular remndelling[J ]. Lancet, 2006,367 (9507) : q56-367.
  • 4de la Porte PW, Lok DJA, van Veldhuisen DJ, et al. Added val- ue of a physician-and-nurse-directed heart failure clinic: results from theDeventer-AIkmaar heart failure study[J]. Heart, 2007, 93(7) :819-825.
  • 5Sharma UC, Pokharel S, van Brakel TJ, et al. Galeetin-3 marks activated maerophages in failure-prone hypertrophied hearts and eont ribut es to cardiac dysfunction[J ]. Circulation, 2004,110 (19) :3121-3128.
  • 6Schroen B, Heymans S, Sharma U, et al. Thrombospundin-2 is essential for myocardial matrix integrity: increased expression i- dentifies failure prone cardiac hypertrophy[J]. Circ Res, 2004,95 (5) :515-522.
  • 7l.iu YH, D'Ambrosio M, l.iao TD. et al. N-acetyl seryl-aspartyl- lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin [J]. Am J Physiol Heart Circ Physiol,2009,296(2) :H404-H412.
  • 8Milting H, Ellinghaus P, Seewald M, et al. Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure pa- tients supported by mechanical circulatory support devices[J].J Heart Lung Transplant ,2008,27(6):589-596.
  • 9Christenson RH,DuhSH, WuAH, et aI. Muhi-cemerdetermi- nation of galectin-3 assay performance characteristics: anatomy of a novel assay for use in heart failure[J]. Clin Biochem,2010,43 (7/8) : 683-690.
  • 10I.ok D, van der Meer P, Andre de la Porte PB, et ai. Plasma ga- lectin-3 level predict left ventricular remodelling determined by se- quential ecboeardiography: results from the l)eventer-Alkmaar Heart failure study[J]. J Am Coil Cardiol,2010,55(10 sl) :AI7. E161-AI7.

共引文献4736

同被引文献93

引证文献10

二级引证文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部